Related Experiment Videos
Normalized thyroxine as a screening test for hypothyroidism in full-term and preterm newborn babies
Israel Journal of Medical Sciences
|February 1, 1979
Summary
Normalized thyroxine (T4N) effectively assesses thyroid function in newborns. This study found T4N useful for monitoring thyroid health in both full-term and preterm infants, including those with respiratory distress syndrome.
Area of Science:
- Neonatal Medicine
- Endocrinology
- Pediatric Health
Background:
- Thyroid hormone levels are critical for newborn development.
- Assessing thyroid function in preterm infants presents unique challenges.
- Standard thyroid function tests may vary between full-term and preterm neonates.
Purpose of the Study:
- To evaluate serum thyroxine (T4), normalized thyroxine (T4N), and thyroid-stimulating hormone (TSH) in newborns.
- To compare thyroid function markers between full-term and preterm infants.
- To determine the utility of T4N as a reliable thyroid function test in neonates.
Main Methods:
- Blood samples were collected from full-term and preterm newborns at 24 hours and 21 days of age.
- Serum T4, T4N, and TSH levels were measured using established assays.
- Infants with respiratory distress syndrome were included for comparative analysis.
Main Results:
- Significant differences in T4 and TSH were observed between full-term and preterm infants at 24 hours, but not T4N.
- By 21 days, TSH remained higher in full-term infants, while T4 levels normalized.
- Thyroid function parameters in preterm infants with respiratory distress syndrome were comparable to healthy preterm infants.
Conclusions:
- Normalized thyroxine (T4N) is a reliable indicator of thyroid function in newborns.
- T4N levels in preterm infants with initially low values normalize by 21 days.
- T4N offers a valuable tool for neonatal thyroid function assessment, especially in preterm infants.